Format

Send to

Choose Destination
See comment in PubMed Commons below
Trends Biochem Sci. 1995 Oct;20(10):435-9.

Cisplatin and DNA repair in cancer chemotherapy.

Author information

1
Department of Chemistry, Massachusetts Institute of Technology, Cambridge 02139, USA.

Abstract

Cisplatin, a DNA-damaging agent, is one of the most widely used anticancer drugs. As with all members of this class of chemotherapeutic compounds, the clinical success of cisplatin is compromised if tumor cells become resistant by various mechanisms, including enhanced DNA repair. In addition to its role in resistance, DNA repair has been linked to the cytotoxic mechanism of cisplatin. DNA damaged by the drug has proved to be a valuable tool for exploring the details of the nucleotide excision repair pathway.

PMID:
8533159
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center